CD19 and systemic lupus erythematosus: In our study of SLE patients, we observed a notable reduction in the proportion of CD19+ HLA-DR+ cells in the PBMC culture when exposed to the UC-MSCcm (27.24 ± 20.76% vs. 33.63 ± 21.24%; p = 0.0005).